Baldwin Brothers LLC Abbott Laboratories Transaction History

Baldwin Brothers LLC

$1.43 Billion
Q3 2024

A detailed history of Baldwin Brothers LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Baldwin Brothers LLC holds 10,026 shares of ABT stock, worth $1.18 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

10,026

Previous 6,494 54.39%

Holding current value

$1.18 Million

Previous $674,000 69.58%

% of portfolio

0.08%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$100.07 - $118.13 $353,447 - $417,235	3,532 Added 54.39%	10,026 $1.14 Million
Q2 2024 Jul 12, 2024	SELL	$100.73 - $112.44 $35,356 - $39,466	-351 Reduced 5.13%	6,494 $674,000
Q1 2024 Apr 12, 2024	SELL	$109.52 - $120.96 $36,141 - $39,916	-330 Reduced 4.6%	6,845 $778,000
Q4 2023 Jan 08, 2024	SELL	$90.19 - $110.4 $38,781 - $47,472	-430 Reduced 5.65%	7,175 $789,000
Q3 2023 Oct 10, 2023	SELL	$95.53 - $114.62 $26,748 - $32,093	-280 Reduced 3.55%	7,605 $736,000
Q2 2023 Jul 14, 2023	BUY	$100.78 - $112.29 $16,427 - $18,303	163 Added 2.11%	7,885 $859,000
Q1 2023 Apr 21, 2023	BUY	$96.86 - $114.01 $3,099 - $3,648	32 Added 0.42%	7,722 $781,000
Q4 2022 Jan 27, 2023	BUY	$95.06 - $111.52 $280,141 - $328,649	2,947 Added 62.13%	7,690 $0
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $8,095 - $9,871	-71 Reduced 1.47%	4,743 $561,000
Q4 2021 Jan 14, 2022	BUY	$115.53 - $141.46 $52,566 - $64,364	455 Added 10.44%	4,814 $678,000
Q2 2021 Jul 30, 2021	BUY	$105.79 - $124.53 $48,980 - $57,657	463 Added 11.88%	4,359 $505,000
Q1 2021 Apr 08, 2021	BUY	$108.84 - $128.23 $3,918 - $4,616	36 Added 0.93%	3,896 $467,000
Q4 2020 Jan 12, 2021	SELL	$105.0 - $114.42 $4,305 - $4,691	-41 Reduced 1.05%	3,860 $422,000
Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $3,207 - $3,895	-35 Reduced 0.89%	3,901 $424,000
Q2 2020 Jul 21, 2020	SELL	$76.57 - $98.0 $2,297 - $2,940	-30 Reduced 0.76%	3,936 $360,000
Q1 2020 Apr 15, 2020	SELL	$62.82 - $91.86 $2,198 - $3,215	-35 Reduced 0.87%	3,966 $313,000
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $22,139 - $24,646	282 Added 7.58%	4,001 $347,000
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $24,961 - $27,065	305 Added 8.93%	3,719 $312,000
Q2 2019 Jul 19, 2019	SELL	$72.88 - $85.0 $21,718 - $25,330	-298 Reduced 8.03%	3,414 $287,000
Q1 2019 Apr 24, 2019	SELL	$66.22 - $80.06 $728 - $880	-11 Reduced 0.3%	3,712 $297,000
Q4 2018 Feb 01, 2019	BUY	$65.56 - $74.27 $7,801 - $8,838	119 Added 3.3%	3,723 $269,000
Q3 2018 Oct 26, 2018	BUY	$60.81 - $73.36 $25,661 - $30,957	422 Added 13.26%	3,604 $264,000
Q2 2018 Jul 24, 2018	BUY	$57.57 - $63.54 $8,635 - $9,531	150 Added 4.95%	3,182 $194,000
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $322 - $344	-6 Reduced 0.2%	3,032 $173,000
Q3 2017 Oct 26, 2017	BUY	$48.06 - $53.64 $146,006 - $162,958	3,038	3,038 $162,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baldwin Brothers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baldwin Brothers LLC with notifications on news.

Account

Baldwin Brothers LLC Abbott Laboratories Transaction History